Nektar Therapeutics (NASDAQ:NKTR)
| 0.7103 Delayed Data As of Mar 28 |  -0.0601 / -7.80%Today’s Change | 0.71 Today|||52-Week Range 6.26 | -68.57% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 230.8M | 165.4M | 307.7M | 1.2B | |
| Cost of Goods Sold | 29.2M | 25.0M | 24.9M | 21.2M | ||
| Depreciation And Amortization | 11.4M | 13.2M | 12.6M | 8.8M | ||
| Operating Expenses | Gross Income | 190.2M | 127.3M | 270.2M | 1.2B | |
| General Expenses | 216.5M | 240.1M | 309.2M | 475.4M | ||
| Research And Development | 176.3M | 195.9M | 260.1M | 394.0M | ||
| Total Operating Expenses | 257.2M | 278.3M | 346.7M | 505.4M | ||
| Non-Operating Expenses | Operating Income | -26.4M | -112.9M | -39.0M | 687.9M | |
| Extraordinary Charge | -17.1M | 0.00 | -20.7M | 0.00 | ||
| Interest Expense On Debt | 38.9M | 42.2M | 41.0M | 42.8M | ||
| Other Expenses | 1.7M | 2.4M | 4.5M | 37.6M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -80.7M | -152.6M | -96.1M | 682.7M | |
| Income Taxes | -506.0K | -876.0K | -616.0K | -1.4M | ||
| Net Income | -81.2M | -153.5M | -96.7M | 681.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 132.5M | 139.6M | 156.0M | 169.6M | |
| Shares To Calculate EPS Diluted | 132.5M | 139.6M | 156.0M | 180.1M | ||
| Earnings Per Share | EPS | -$0.61 | -$1.10 | -$0.62 | $3.78 | |
| EPS Diluted | -$0.61 | -$1.10 | -$0.62 | $3.78 | ||
